IRCT20101014004934N3RecruitingPhase 3
Investigation of the effect of curcumin supplementation on clinical status, inflammatory factors, oxidative stress biomarkers in patients with rheumatoid arthritis
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 years to 70 years (—)
- Sex
- All
Inclusion Criteria
- •Patients with rheumatoid arthritis based on diagnostic criteria
- •Age 20-70 years
Exclusion Criteria
- •Reluctance to cooperate
- •Hypothyroidism or hyperthyroidism
- •Consumption of any type of supplement (vitamins, salts, etc.) by the patient during the last 3 months
- •Having any acute and active infection
Investigators
Similar Trials
Recruiting
Phase 3
Curcumin supplementation in cancer patients under cisplatin treatmentCancer types.Malignant neoplasm of ovary, Malignant neoplasm of breastC56, C50IRCT20190305042939N2Esfahan University of Medical Sciences50
Recruiting
Phase 2
The effect of Curcumin supplementation on mortality rate and clinical status in patients with traumaIRCT20130829014521N21Mashhad University of Medical Sciences327
Recruiting
Phase 3
The effect of Curcumin on Polycystic Ovary Syndrome.IRCT20180503039511N1Esfahan University of Medical Sciences60
Recruiting
Phase 3
the effect of curcumin supplementation on depression, anxiety, pain and BDNF serum concentration in patients with gastrointestinal cancerGastrointestinal Malignancy.Malignant neoplasm of ill-defined sites within the digestive systemC26.9IRCT20240521061860N1Zahedan University of Medical Sciences64
Recruiting
Unknown
Curcumin and the gut microbiota alterationsObesity and weight gain.Overweight and obesityIRCT20240209060948N1Islamic Azad University80